Sun Pharmaceutical Industries Ltd (SUN.BO)
** Shares in India's Sun Pharmaceuticals Industries Ltd rose as much as 3.4 percent on Wednesday morning to a high of 790 rupees
** Announcement allays capital allocation concerns of investors - Analysts
** Indian drug makers attract short positions in derivatives even after being oversold
** Says new disclosure of Halol being classified as official action initiated (OAI) flag increases the chances of a warning letter
** Sun Pharmaceutical Industries slumps 5.3 pct, Dr.Reddy's Laboratories down 1.7 pct and Lupin falls 1.6 pct
** Traders cite optimism tied to launch of Keveyis drug in the U.S. market by unit Taro Pharmaceutical Industries
MUMBAI Sun Pharmaceutical Industries Ltd, India's largest drugmaker by sales, said it is looking to divest a manufacturing plant in Ireland as it tries to control costs that have spiralled since it bought Ranbaxy Laboratories Ltd.
MUMBAI, Sept 10 Sun Pharmaceutical Industries Ltd, India's largest drugmaker by sales, said it is looking to divest a manufacturing plant in Ireland as it tries to control costs that have spiralled since it bought Ranbaxy Laboratories Ltd.
* Says USFDA approved supplemental new drug application for ximino extended-release capsules 45 mg, 90 mg and 135 mg Source text for Eikon: http://bit.ly/1hMr5DX Further company coverage:
** Cites integration with Ranbaxy, price hikes at unit Taro and improvement in US supplies as key reason for the upgrade